Chemours (NYSE: CC) reported Q2 EPS of ($0.10), which may not compare with the analyst estimate of $0.17. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.42 billion.

For earnings history and earnings-related data on Chemours (CC) click here.